23 related articles for article (PubMed ID: 1477091)
1. Construction of microarrays for genotyping of DQA using unmodified 45-mer oligonucleotide.
Yin BC; Yue F; Ye BC
Mol Biotechnol; 2007 Jun; 36(2):142-50. PubMed ID: 17914193
[TBL] [Abstract][Full Text] [Related]
2. Non-radioactive oligotyping for HLA-DR1-DRw10 using polymerase chain reaction, digoxigenin-labelled oligonucleotides and chemiluminescence detection.
Nevinny-Stickel C; Hinzpeter M; Andreas A; Albert ED
Eur J Immunogenet; 1991; 18(5-6):323-32. PubMed ID: 1772877
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of HLA-DRB1 typing by standard serology and hybridization of non-radioactive sequence-specific oligonucleotide probes to PCR-amplified DNA.
Mickelson E; Smith A; McKinney S; Anderson G; Hansen JA
Tissue Antigens; 1993 Feb; 41(2):86-93. PubMed ID: 8475493
[TBL] [Abstract][Full Text] [Related]
4. A simple method of HLA-DRB typing using enzymatically amplified DNA and immobilized probes on microtiter plate.
Kawai S; Maekawajiri S; Tokunaga K; Juji T; Yamane A
Hum Immunol; 1994 Oct; 41(2):121-6. PubMed ID: 7860356
[TBL] [Abstract][Full Text] [Related]
5. Biotinylated DRB sequence-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in eurotransplant.
Verduyn W; Doxiadis II; Anholts J; Drabbels JJ; Naipal A; D'Amaro J; Persijn GG; Giphart MJ; Schreuder GM
Hum Immunol; 1993 May; 37(1):59-67. PubMed ID: 8376188
[TBL] [Abstract][Full Text] [Related]
6. Generic HLA-DRB1 gene oligotyping by a nonradioactive reverse dot-blot methodology.
Eliaou JF; Palmade F; Avinens O; Edouard E; Ballaguer P; Nicolas JC; Clot J
Hum Immunol; 1992 Dec; 35(4):215-22. PubMed ID: 1293086
[TBL] [Abstract][Full Text] [Related]
7. International Cell Exchange, 1994.
Lau M; Terasaki PI; Park MS
Clin Transpl; 1994; ():467-88. PubMed ID: 7547576
[TBL] [Abstract][Full Text] [Related]
8. Techniques used to define human MHC antigens: polymerase chain reaction and oligonucleotide probes.
Wordsworth P
Immunol Lett; 1991 Jul; 29(1-2):37-9. PubMed ID: 1916922
[TBL] [Abstract][Full Text] [Related]
9. Implication of structural class II gene polymorphism for the concept of serologic specificities.
Möller E; Carlsson B; Wallin J
Immunol Rev; 1985 Jul; 85():107-28. PubMed ID: 2412948
[TBL] [Abstract][Full Text] [Related]
10. Dr. Pring's Exposition of the Principles of Pathology and Therapeutics.
Med Chir Rev J Med Sci Anal Ser; 1823 Sep; 4(14):241-277. PubMed ID: 29917566
[No Abstract] [Full Text] [Related]
11. One-step molecular HLA-DR prescreening employing a set of 14 sequence specific oligonucleotides in a non-radioactive tetramethylammonium chloride hybridization protocol.
Sorg UR; Enczmann J; Sorg RV; Wernet P
Eur J Immunogenet; 1992 Dec; 19(6):391-401. PubMed ID: 1477091
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
